Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine ...

Judging by the present cost of production at the clinical research stage, Cheng, who previously worked as a biological ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Vaccine stocks have been under significant pressure since the FDA's top vaccine official resigned. Seeking Alpha analysts ...

Phospholipids are key components of cell membranes, and are used in the creation of lipid nanoparticles (LNPs) for targeted drug delivery. DOPE-Cx can form a special structure called a “cubic phase,” ...

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

At present, over 45 industry players are engaged in the development of mRNA drug candidates for a wide range of disease indications. The success of COVID-19 vaccines, growing research activity and ...

The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...